Keystone E - Search Results

1

Safety of the selective costimulation modulator abatacept in rheumatoid arthritis patients receiving background biologic and nonbiologic disease-modifying antirheumatic drugs: A one-year randomized, placebo-controlled study.

Weinblatt M, Combe B, Covucci A, Aranda R, Becker JC, Keystone E. Weinblatt M, et al. Among authors: keystone e. Arthritis Rheum. 2006 Sep;54(9):2807-16. doi: 10.1002/art.22070. Arthritis Rheum. 2006. PMID: 16947384 Clinical Trial.

2

Mixed leukocyte reaction in rheumatoid arthritis.

Keystone EC, Gladman DD, Urowitz MB, Clarke DA, Falk JA, Osoba D, Gordon DA. Keystone EC, et al. Arthritis Rheum. 1976 May-Jun;19(3):532-8. doi: 10.1002/art.1780190304. Arthritis Rheum. 1976. PMID: 132936

3

Structure of T cell antigen receptor beta chain in synovial fluid cells from patients with rheumatoid arthritis.

Keystone EC, Minden M, Klock R, Poplonski L, Zalcberg J, Takadera T, Mak TW. Keystone EC, et al. Arthritis Rheum. 1988 Dec;31(12):1555-7. doi: 10.1002/art.1780311213. Arthritis Rheum. 1988. PMID: 2904267

4

Elevated soluble interleukin-2 receptor levels in the sera and synovial fluids of patients with rheumatoid arthritis.

Keystone EC, Snow KM, Bombardier C, Chang CH, Nelson DL, Rubin LA. Keystone EC, et al. Arthritis Rheum. 1988 Jul;31(7):844-9. doi: 10.1002/art.1780310704. Arthritis Rheum. 1988. PMID: 3134896

5

Impaired antigen-specific suppressor cell activity in patients with rheumatoid arthritis.

Keystone EC, Gladman DD, Buchanan R, Cane D, Poplonski L. Keystone EC, et al. Arthritis Rheum. 1980 Nov;23(11):1246-50. doi: 10.1002/art.1780231103. Arthritis Rheum. 1980. PMID: 6160858

6

Takayasu arteritis with acute interstitial pneumonia and coronary vasculitis: expanding the spectrum. Report of a case.

Kreidstein SH, Lytwyn A, Keystone EC. Kreidstein SH, et al. Among authors: keystone ec. Arthritis Rheum. 1993 Aug;36(8):1175-8. doi: 10.1002/art.1780360819. Arthritis Rheum. 1993. PMID: 8102058 Review.

7

Restricted cytokine expression in rheumatoid arthritis.

Chen E, Keystone EC, Fish EN. Chen E, et al. Among authors: keystone ec. Arthritis Rheum. 1993 Jul;36(7):901-10. doi: 10.1002/art.1780360706. Arthritis Rheum. 1993. PMID: 8318038

8

Biologic agents for the treatment of rheumatoid arthritis.

Strand V, Keystone E, Breedveld F. Strand V, et al. Among authors: keystone e. Rheum Dis Clin North Am. 1996 Feb;22(1):117-32. doi: 10.1016/s0889-857x(05)70265-9. Rheum Dis Clin North Am. 1996. PMID: 8907068 Review.

9

Rheumatoid arthritis synovial fibroblast and U937 macrophage/monocyte cell line interaction in cartilage degradation.

Scott BB, Weisbrot LM, Greenwood JD, Bogoch ER, Paige CJ, Keystone EC. Scott BB, et al. Among authors: keystone ec. Arthritis Rheum. 1997 Mar;40(3):490-8. doi: 10.1002/art.1780400315. Arthritis Rheum. 1997. PMID: 9082937

10

Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial.

Moreland LW, Schiff MH, Baumgartner SW, Tindall EA, Fleischmann RM, Bulpitt KJ, Weaver AL, Keystone EC, Furst DE, Mease PJ, Ruderman EM, Horwitz DA, Arkfeld DG, Garrison L, Burge DJ, Blosch CM, Lange ML, McDonnell ND, Weinblatt ME. Moreland LW, et al. Among authors: keystone ec. Ann Intern Med. 1999 Mar 16;130(6):478-86. doi: 10.7326/0003-4819-130-6-199903160-00004. Ann Intern Med. 1999. PMID: 10075615 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results